DT Consultants, LLC v. Howmedica Osteonics Corp.

CourtDistrict Court, D. Maryland
DecidedJuly 7, 2021
Docket1:17-cv-01697
StatusUnknown

This text of DT Consultants, LLC v. Howmedica Osteonics Corp. (DT Consultants, LLC v. Howmedica Osteonics Corp.) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
DT Consultants, LLC v. Howmedica Osteonics Corp., (D. Md. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND

DT CONSULTANTS, LLC, :

Plaintiff, :

v. : Civil Action No. GLR-17-1697

HOWMEDICA OSTEONICS CORP., :

Defendant. :

MEMORANDUM OPINION

THIS MATTER is before the Court on Plaintiff DT Consultants, LLC’s (“DT”) Petition for Attorneys’ Fees and Costs (ECF No. 162). The Petition is ripe for disposition, and no hearing is necessary. See Local Rule 105.6 (D.Md. 2021). For the reasons outlined below, the Court will grant in part and deny in part the Petition. I. BACKGROUND This dispute involves the breach of a Sublicense Agreement between DT and Defendant Howmedica Osteonics Corp. (“Howmedica”).1 On September 14, 2020, the Court issued a Memorandum Opinion denying the parties’ cross-motions for summary judgment, explaining that DT was entitled to damages “equal to the unpaid Update Royalties for 2017, plus interest and other fees as provided by the terms of the Sublicense.”

1 The Court sets forth a detailed explanation of the facts in its September 14, 2020 Memorandum Opinion. (See ECF No. 160). Defined terms in the present Opinion have the same meaning as those used in the September 14, 2020 Opinion. (Mem. Op. at 18, ECF No. 160). Accordingly, the Court directed DT to move for an award of damages. On September 23, 2020, DT filed a motion styled as a “Petition for Attorneys’ Fees

and Costs.” (ECF No. 162). Howmedica filed its Opposition on September 30, 2020. (ECF No. 163). DT filed a Reply on October 8, 2020, followed by Howmedica’s Surreply on October 14, 2020. (ECF Nos. 164, 167). II. DISCUSSION A. Damages

The Court first considers the amount of damages owed for Howmedica’s breach of the Sublicense Agreement. In its September 14, 2020 Memorandum Opinion, the Court explained that, pursuant to the express terms of the Sublicense, the unpaid Update Royalties for 2017 were equal to $37,800.00. (See Mem. Op. at 17–18). As such, the Court noted that total damages were “equal to the unpaid Update Royalties for 2017, plus interest and

other fees as provided by the terms of the Sublicense.” (Id. at 18). The Court thus directed DT to file “a Motion for Award of Damages consistent with the foregoing Memorandum Opinion.” (Order at 2, ECF No. 161). Despite this directive, DT’s Petition merely states that damages are equal to $37,800 and does not provide any specific request for interest. (See Pl.’s Pet. Att’ys’ Fees & Costs [“Pet.”] at 18, ECF No. 162). Accordingly, the Court

will simply award DT $37,800.00 in damages. B. Indemnification The majority of DT’s Petition is spent discussing its entitlement to attorneys’ fees and other costs pursuant to the Sublicense Agreement, which provides that Howmedica must indemnify DT for reasonable attorneys’ fees and costs that DT “paid, suffered or incurred” as a result of litigating an action for breach of contract. (Sublicense Agreement § 5.2.1, ECF No. 4-1). Howmedica contends that DT has not adequately demonstrated that

it has paid, suffered, or incurred any attorneys’ fees or litigation costs in this matter and, in any event, DT’s requested expenses should be reduced because they are unreasonable in light of the facts and circumstances at hand. Separately, Howmedica argues that DT’s request for unspecified “Collection Costs” is premature. The Court addresses these arguments in turn.

1. Attorneys’ Fees DT admits it has not yet paid any attorneys’ fees in this matter. Nonetheless, DT contends it has incurred $624,793.98 in attorneys’ fees based upon the hourly rates of counsel and paralegals from the law firm Schulman, Hershfield & Gilden, P.A. (“SH&G”), which DT retained in connection with this dispute. Howmedica responds that DT has not

incurred these fees because the engagement letter between DT and SH&G (the “Engagement Letter”) is a contingency fee agreement, not an hourly fee agreement, and DT has yet to recover anything from Howmedica. At bottom, the Court agrees with Howmedica. The Engagement Letter states that DT will “pay SH&G on a contingency fee basis.”

(Engagement Ltr. at 1, ECF No. 162-4). Specifically, the Engagement Letter provides that DT shall “remit[] to SH&G Forty Percent (40%) of the amount recovered from said lawsuit[,]” which “shall be paid directly to [SH&G] immediately upon recovery of any sum(s).” (Id.). In other words, DT’s attorneys’ fees become payable to SH&G upon DT’s “recovery” from Howmedica. As such, DT does not incur attorneys’ fees until that time.2 As Howmedica points out, DT has not yet “recover[ed] [] any sum(s)” because “Howmedica has not paid DT anything for this lawsuit, and judgment has not been entered

(much less become final and satisfied).” (Def.’s Opp’n Pet. Att’ys’ Fees & Costs [“Opp’n”] at 6, ECF No. 163). Because DT has not yet recovered anything from this lawsuit, DT has yet to incur any fees under the Engagement Letter. Thus, DT is not presently entitled to indemnification under the Sublicense Agreement. Despite the clear language in the Engagement Letter, DT argues that attorney Leslie

D. Hershfield is nonetheless entitled to his hourly rate, explaining that “if this matter settled . . . counsel would have received a contingent amount of the settlement” but “since a judgment was rendered by this Court, the fee is hourly.” (Pet. at 16). The Court is not persuaded. The Engagement Letter states that fees will be calculated using Hershfield’s hourly rate of $550.00 only “[i]f the United States District Court or any other Federal Court

finds that the contingency fee of 40% is inapplicable.” (Engagement Ltr. at 1). The Court sees no reason why the contingency fee would be inapplicable here. Indeed, the Court agrees with Howmedica’s observation that this language “likely refers to a situation in which the total damages recovered [were] large and, under [Local] Rule 1.5, the Court found the 40% contingency fee unreasonable and therefore inapplicable.” (Opp’n at 6 n.3).

Because there is no language in the Engagement Letter supporting DT’s assertion that

2 In general, “incur” means to bring on oneself a liability or expense. See Weichert Co. of Md. v. Faust, 19 A.3d 393, 406 (Md. 2011) (citing Black’s Law Dictionary 782 (8th ed. 2004)). SH&G must be paid by the hour, DT’s request for hourly attorneys’ fees cannot be sustained. DT also argues that it is entitled to its requested fees because “attorney’s fees are

incurred ‘when services are rendered.’” (Pl.’s Reply Supp. Pet. Att’ys’ Fees & Costs [“Reply”] at 5, ECF No. 164-1 (quoting Worsham v. Greenfield, 78 A.3d 358, 360 (Md. 2013)). In support of this argument, DT cites to Weichert Co. of Maryland v. Faust, 19 A.3d 393 (Md. 2011), which observed that the “the term ‘incur’ only refers to an expense incurred on behalf of a party, but not necessarily paid by the party.” Id. at 408. As

Howmedica points out, however, Weichert involved a fee-shifting provision that referred generally to “fees incurred” without “specify[ing] by whom they must be incurred.” Id. at 398. The Weichert court held that in such instances, a court should interpret “incurred” to mean fees “incurred on [the party’s] behalf, regardless of who actually paid the costs.” Id. Unlike the fee-shifting provision in Weichert, the Sublicense Agreement here clearly

specifies that DT must pay, suffer, or incur the expenses in order to be entitled to indemnification; thus, Weichert’s reasoning does not apply. Moreover, even if Weichert were relevant to the present case, its reasoning would nonetheless require the fees to have been “paid” by another party on DT’s behalf. See id. at 398.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Farrar v. Hobby
506 U.S. 103 (Supreme Court, 1992)
Myers v. Kayhoe
892 A.2d 520 (Court of Appeals of Maryland, 2006)
Diamond Point Plaza Ltd. Partnership v. Wells Fargo Bank, N.A.
929 A.2d 932 (Court of Appeals of Maryland, 2007)
Monmouth Meadows Homeowners Ass'n v. Hamilton
7 A.3d 1 (Court of Appeals of Maryland, 2010)
Weichert Co. v. Faust
19 A.3d 393 (Court of Appeals of Maryland, 2011)
Eileen McAfee v. Christine Boczar
738 F.3d 81 (Fourth Circuit, 2013)
Friolo v. Frankel
91 A.3d 1156 (Court of Appeals of Maryland, 2014)
Ochse v. Henry
88 A.3d 773 (Court of Special Appeals of Maryland, 2014)
Worsham v. Greenfield
78 A.3d 358 (Court of Appeals of Maryland, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
DT Consultants, LLC v. Howmedica Osteonics Corp., Counsel Stack Legal Research, https://law.counselstack.com/opinion/dt-consultants-llc-v-howmedica-osteonics-corp-mdd-2021.